1. Home
  2. EOLS vs TRC Comparison

EOLS vs TRC Comparison

Compare EOLS & TRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • TRC
  • Stock Information
  • Founded
  • EOLS 2012
  • TRC 1843
  • Country
  • EOLS United States
  • TRC United States
  • Employees
  • EOLS N/A
  • TRC N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • TRC Real Estate
  • Sector
  • EOLS Health Care
  • TRC Finance
  • Exchange
  • EOLS Nasdaq
  • TRC Nasdaq
  • Market Cap
  • EOLS 444.0M
  • TRC 432.5M
  • IPO Year
  • EOLS 2018
  • TRC N/A
  • Fundamental
  • Price
  • EOLS $7.03
  • TRC $16.37
  • Analyst Decision
  • EOLS Strong Buy
  • TRC
  • Analyst Count
  • EOLS 4
  • TRC 0
  • Target Price
  • EOLS $21.25
  • TRC N/A
  • AVG Volume (30 Days)
  • EOLS 2.0M
  • TRC 99.3K
  • Earning Date
  • EOLS 11-05-2025
  • TRC 11-06-2025
  • Dividend Yield
  • EOLS N/A
  • TRC N/A
  • EPS Growth
  • EOLS N/A
  • TRC N/A
  • EPS
  • EOLS N/A
  • TRC 0.11
  • Revenue
  • EOLS $285,823,000.00
  • TRC $46,420,000.00
  • Revenue This Year
  • EOLS $13.39
  • TRC N/A
  • Revenue Next Year
  • EOLS $26.85
  • TRC N/A
  • P/E Ratio
  • EOLS N/A
  • TRC $148.26
  • Revenue Growth
  • EOLS 15.10
  • TRC 15.71
  • 52 Week Low
  • EOLS $5.71
  • TRC $14.71
  • 52 Week High
  • EOLS $17.12
  • TRC $19.39
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 53.48
  • TRC 54.43
  • Support Level
  • EOLS $6.53
  • TRC $15.54
  • Resistance Level
  • EOLS $7.01
  • TRC $16.17
  • Average True Range (ATR)
  • EOLS 0.41
  • TRC 0.39
  • MACD
  • EOLS -0.01
  • TRC 0.02
  • Stochastic Oscillator
  • EOLS 45.53
  • TRC 73.23

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About TRC Tejon Ranch Co

Tejon Ranch Co is a diversified real estate development and agribusiness company committed to responsibly using its land and resources to meet the housing, employment, and lifestyle needs of Californians and create value for its shareholders. It has five segments namely Real Estate - Commercial/Industrial, Real Estate - Resort/Residential, Mineral Resources, Farming, and Ranch Operations.

Share on Social Networks: